Yujie Ren

3.1k citations
63 papers · 1.4k indexed · 1 hit paper · h-index 20
Topics
interferon and immune responses (13 papers)Viral Infections and Immunology Research (5 papers)RNA Research and Splicing (5 papers)

In The Last Decade

Yujie Ren

56 papers receiving 1.4k citations

Hit Papers

The ORF3a protein of SARS-CoV-2 induces apoptosis in cells20202026202220242020100200300

Peers

Yujie Ren
Comparison fields: 5 of 119
  • Molecular Biology 580
  • Infectious Diseases 512
  • Immunology 369
  • Epidemiology 227
  • Cancer Research 141
Replace Lang Chen with:
Lang Chen China
Ning Yang China
Liping Yang China
Guoli Li China
Antonio Di Grazia Italy
Miaomiao Zhang China
Yan Fang China
Georgia Schäfer South Africa
Yujie Ren relative to Lang Chen China Lang Chen's profile →
Citations per field
00.5×2.7×
Lang Chen · 1×
Citations per year

Countries citing papers authored by Yujie Ren

Since Specialization
Citations

This map shows the geographic impact of Yujie Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujie Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujie Ren more than expected).

Fields of papers citing papers by Yujie Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujie Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujie Ren. The network helps show where Yujie Ren may publish in the future.

Co-authorship network of co-authors of Yujie Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Yujie Ren. A scholar is included among the top collaborators of Yujie Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujie Ren. Yujie Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 1
4 0
5 2
6 2
7 1
8 5
9 1
10 10
11 0
12 7
13 4
14 3
15
The ORF3a protein of SARS-CoV-2 induces apoptosis in cellsbreakdown →
345
16 24
17 1
18 9
19 34
20 107

About Yujie Ren

Yujie Ren is a scholar working on Immunology, Infectious Diseases and Cardiology and Cardiovascular Medicine, having authored 63 papers that have together received 1.4k indexed citations. Recurring topics across this work include interferon and immune responses (13 papers), Viral Infections and Immunology Research (5 papers) and RNA Research and Splicing (5 papers). The work is most often cited by research in Infectious Diseases (512 citations), Immunology (369 citations) and Cancer Research (141 citations). Yujie Ren has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yang Qiu, Xi Zhou, Muhan Huang, Ting Shu, Yang Han, Jingfang Mu, Wei Zhou, Bo Zhong, Di Wu and Chong Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026